Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | glutathione reductase | 0.0055 | 0.0462 | 0.113 |
Plasmodium falciparum | thioredoxin reductase | 0.0055 | 0.0462 | 0.5 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.013 | 0.2921 | 0.8963 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.014 | 0.3265 | 0.6736 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0126 | 0.28 | 0.5619 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0126 | 0.28 | 0.5619 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0101 | 0.1975 | 0.5905 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.014 | 0.3265 | 0.6736 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.1597 | 0.3902 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.1927 | 0.4709 |
Loa Loa (eye worm) | hypothetical protein | 0.0165 | 0.4092 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0055 | 0.0462 | 0.0553 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.013 | 0.2921 | 0.6436 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0126 | 0.28 | 0.5619 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0126 | 0.28 | 0.5619 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0345 | 1 | 1 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0053 | 0.0376 | 0.0739 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0229 | 0.0189 |
Mycobacterium tuberculosis | Probable reductase | 0.0126 | 0.28 | 0.5619 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.013 | 0.2921 | 0.2578 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0345 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0175 | 0.4422 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0055 | 0.0462 | 0.0233 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0345 | 1 | 1 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0053 | 0.0376 | 0.0531 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.014 | 0.3265 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0163 | 0.4015 | 0.3871 |
Brugia malayi | Bromodomain containing protein | 0.009 | 0.1591 | 0.3247 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0101 | 0.1975 | 0.4161 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.013 | 0.2921 | 0.8963 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0055 | 0.0462 | 0.1018 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0084 | 0.1409 | 0.4076 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0101 | 0.1975 | 0.424 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.023 | 0.0563 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0126 | 0.28 | 0.5619 |
Toxoplasma gondii | hypothetical protein | 0.0056 | 0.047 | 0.0032 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.1779 | 0.4348 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0182 | 0.4623 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0059 | 0.0585 | 0.0358 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0055 | 0.0462 | 0.113 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0053 | 0.0376 | 0.0739 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0055 | 0.0462 | 0.0233 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.013 | 0.2921 | 0.591 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.014 | 0.3242 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0055 | 0.0462 | 0.1018 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0101 | 0.1975 | 0.424 |
Plasmodium falciparum | glutathione reductase | 0.0055 | 0.0462 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.014 | 0.3265 | 0.6736 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0101 | 0.1975 | 0.5905 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0163 | 0.4015 | 0.3725 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.013 | 0.2921 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0182 | 0.4623 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0055 | 0.0462 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0101 | 0.1975 | 0.5905 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.013 | 0.2921 | 0.6436 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0101 | 0.1975 | 0.424 |
Brugia malayi | PHD-finger family protein | 0.0058 | 0.0559 | 0.0783 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0048 | 0.0229 | 0.0559 |
Plasmodium vivax | glutathione reductase, putative | 0.0055 | 0.0462 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.023 | 0.0563 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0101 | 0.1975 | 0.5905 |
Schistosoma mansoni | bromodomain containing protein | 0.0148 | 0.3518 | 0.7821 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0101 | 0.1975 | 0.4825 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.014 | 0.3242 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0084 | 0.1409 | 0.4076 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0163 | 0.4015 | 0.3871 |
Brugia malayi | glutathione reductase | 0.0055 | 0.0462 | 0.0553 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.